John DeGroot

7.0k citations

32 papers · 3.5k indexed · 1 hit paper · h-index 15

Impact in

Genetics top 0.2%
- Glioma Diagnosis and Treatment
Radiology, Nuclear Medicine and Imaging top 1%
- Radiomics and Machine Learning in Medical Imaging
- MRI in cancer diagnosis
- Medical Imaging Techniques and Applications
- Advanced MRI Techniques and Applications

Papers in ⓘ

Genetics 19
- Glioma Diagnosis and Treatment 19
Neurology 7
- Neuroblastoma Research and Treatments 3

Co-authors: Patrick Y. Wen (8 shared papers)Mark R. Gilbert (5 shared papers)Martin J. van den Bent (2 shared papers)Michael A. Vogelbaum (2 shared papers)David R. Macdonald (2 shared papers)Marc C. Chamberlain (2 shared papers)Timothy F. Cloughesy (4 shared papers)Kathleen R. Lamborn (2 shared papers)
Journals: Neuro-Oncology (11 papers)ESMO Open (2 papers)Journal of Neuro-Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer (1 paper)
Partner nations: United States Canada Switzerland

In The Last Decade

John DeGroot

32 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group 2010 · 2.7k citations

Peers

Countries citing papers authored by John DeGroot

Since Specialization

Citations

This map shows the geographic impact of John DeGroot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John DeGroot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John DeGroot more than expected).

Fields of papers citing papers by John DeGroot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John DeGroot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John DeGroot. The network helps show where John DeGroot may publish in the future.

Co-authors

The 25 scholars most cited alongside John DeGroot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John DeGroot Line = papers co-authored together John DeGroot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Journal of Clinical Oncology ·Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang Hit paper breakdown →	2010	2726
2	Macroglobulin from Human Plasma Which Forms an Enzymatically Active Compound with Trypsin Science ·John W. Mehl, William O'Connell, John DeGroot	1964	142
3	Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation Neuroreport ·John DeGroot, Shengtai Zhou, Susan M. Carlton	2000	141
4	Clinical trial end points for high-grade glioma: the evolving landscape Neuro-Oncology ·D. A. Reardon, E. Galanis, John DeGroot, Timothy F. Cloughesy, Jeffrey S. Wefel, Kathleen R. Lamborn, A. B. Lassman, Mark R. Gilbert, John H. Sampson, Wolfgang Wick, Marc C. Chamberlain, David R. Macdonald, Minesh P. Mehta, Michael A. Vogelbaum, Shannon Chang, Martin J. van den Bent, Patrick Y. Wen	2011	89
5	Estimation of biophysical characteristics for highly variable mixed-conifer stands using small-footprint lidar Canadian Journal of Forest Research ·Jennifer Jensen, K. S. Humes, Tamara Conner, Christopher J. Williams, John DeGroot	2006	62
6	The reorganization of μ opioid receptors in the rat dorsal horn following peripheral axotomy Neuroscience Letters ·John DeGroot, R. E. Coggeshall, Susan M. Carlton	1997	43
7	Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy Clinical Cancer Research ·Martina Ott, Cynthia Kassab, Anantha Marisetty, Yuuri Hashimoto, Jun Wei, Daniel Zamler, Jia-Shiun Leu, Karl-Heinz Tomaszowski, Aria Sabbagh, Dexing Fang, Pravesh Gupta, Waldemar Priebe, Rafał Zieliński, Jared K. Burks, James P. Long, Ling-Yuan Kong, Gregory N. Fuller, John DeGroot, Erik P. Sulman, Amy B. Heimberger	2020	41
8	Clinical and prognostic features of adult patients with gangliogliomas Neuro-Oncology ·Shlomit Yust‐Katz, Mark D. Anderson, D. Liu, Jing Wu, Ye Yuan, Adriana Olar, Gregory N. Fuller, P. D. Brown, John DeGroot	2013	33
9	Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539 International Journal of Radiation OncologyBiologyPhysics ·Leland Rogers, P. Zhang, Michael A. Vogelbaum, Arie Perry, Landon Ashby, Jignesh Modi, Anthony M. Alleman, James M. Galvin, David Brachman, Joseph M. Jenrette, John DeGroot, Joseph Bovi, Maria Werner‐Wasik, Jonathan Knisely, Minesh P. Mehta	2015	29
10	NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma Cancer ·Eudocia Q. Lee, Peixin Zhang, Patrick Y. Wen, Elizabeth R. Gerstner, David A. Reardon, Kenneth Aldape, John DeGroot, Edward Pan, Jeffrey J. Raizer, Lyndon J. Kim, Steven J. Chmura, H. Ian Robins, Jennifer Connelly, James Battiste, John L. Villano, Naveed Wagle, Ryan Merrell, Merideth M Wendland, Minesh P. Mehta	2020	28
11	Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study ESMO Open ·Mark Rosenthal, Paul M. Clément, Mario Campone, Miguel Gil‐Gil, John DeGroot, Olivier Chinot, Ahmed Idbaïh, Hui Gan, Jeffrey Raizer, Patrick Y. Wen, Estela Pineda, V Donnet, David Mills, Mona El-Hashimy, Warren Mason	2020	27
12	Preparation of Human Plasma Prothrombin and Some of Its Sedimentation Properties Journal of Biological Chemistry ·Gerard F. Lanchantin, Jack Friedmann, John DeGroot, John W. Mehl	1963	27
13	Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma ESMO Open ·Patrick Y. Wen, Jordi Rodón, Warren Mason, J.T. Beck, John DeGroot, V Donnet, David Mills, Mona El-Hashimy, Mark Rosenthal	2020	26
14	Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma Journal of Neuro-Oncology ·Mohamed A. Hamza, Jacob Mandel, Charles A. Conrad, Mark R. Gilbert, W.K. Alfred Yung, Vinay K. Puduvalli, John DeGroot	2014	24
15	High affinity of α-foetoprotein for arachidonate and other fatty acids Biochemical Journal ·Roland Carlsson, Thomas Estes, John DeGroot, Joseph T. Holden, Erkki Ruoslahti	1980	24
16	Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients Journal of Neuro-Oncology ·David Cachia, Nabil Elshafeey, Carlos Kamiya-Matsuoka, Masumeh Hatami, Kristin Alfaro-Munoz, Jacob Mandel, Rivka R. Colen, John DeGroot	2017	14
17	Composition of lipids bound to pure cytochrome P‐450 of cholesterol side‐chain cleavage enzyme from bovine adrenocortical mitochondria Lipids ·Peter F. Hall, M. Watanuk, John DeGroot, George Rouser	1979	14
18	PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM Neuro-Oncology ·Patrick Y. Wen, W.K. Alfred Yung, Ingo K. Mellinghoff, Shakti Ramkissoon, Barbara D. Alexander, Mikael L. Rinne, H. Colman, Antonio Omuro, Lisa M. DeAngelis, Mark R. Gilbert, John DeGroot, Timothy F. Cloughesy, E. Q. Lee, Lakshmi Nayak, Anand Asha S, Tracy T. Batchelor, Susan M. Chang, Michael D. Prados, David A. Reardon, K. L. Ligon	2014	8
19	ATCT-27NRG ONCOLOGY/RTOG 0929: A RANDOMIZED PHASE I/II STUDY OF ABT-888IN COMBINATION WITH TEMOZOLOMIDE IN RECURRENT TEMOZOLOMIDE RESISTANT GLIOBLASTOMA Neuro-Oncology ·H. Ian Robins, Jianwen Zhang, Mark R. Gilbert, Arnab Chakravarti, John DeGroot, Sean Grimm, Fen Wang, Frank S. Lieberman, Andra Krauze, Anand K. Sharma, Nimish Mohile, Andrew Y. Kee, Howard Colman, Robert Cavaliere, Santosh Kesari, Steven J. Chmura, Minesh P. Mehta	2015	4
20	Integrated phase II/III clinical trials in oncology: A case study Clinical Trials ·Meihua Wang, James J. Dignam, Qiang E Zhang, John DeGroot, Minesh P. Mehta, Sally Hunsberger	2012	4

About John DeGroot

John DeGroot is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 3.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Neuroblastoma Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Meningioma and schwannoma management (2 papers). The work is most often cited by research in Genetics (2.6k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations), Cancer Research (500 citations), Neurology (404 citations) and Pulmonary and Respiratory Medicine (848 citations). John DeGroot has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Patrick Y. Wen, Mark R. Gilbert, Martin J. van den Bent, Michael A. Vogelbaum, David R. Macdonald, Marc C. Chamberlain, Timothy F. Cloughesy, Kathleen R. Lamborn, Wolfgang Wick and David A. Reardon. Their work appears in journals such as Neuro-Oncology, ESMO Open, Journal of Neuro-Oncology, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact